PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 2, 2024The American Journal of Gastroenterology1 citations

Insurer Medication Utilization Barriers are Associated with Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An IBD Partners Survey

View Full Paper
BCBrad D. ConstantMLMillie D. LongFSFrank I. Scott

Key Points

Key points are not available for this paper at this time.

Abstract

Insurer-mandated barriers to timely initiation of advanced therapies used to treat inflammatory bowel disease (IBD) have been shown to worsen clinical outcomes and increase healthcare utilization, yet rarely alter the medication ultimately prescribed.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Constant et al. (2024) studied this question.

synapsesocial.com/papers/68e6bd3bb6db64358763d6b1https://doi.org/10.14309/ajg.0000000000002851
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Insurance Companies' Poor Adherence to Guidelines for Moderate-to-Severe Ulcerative Colitis/Crohn's Disease Management2024 · 13 citations
  2. 2Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): Methodology and initial results2012 · 112 citations
  3. 3A Mixed-methods Assessment of the Impact of Insurance Issues on the Emotional and Physical Health of Patients With Inflammatory Bowel Disease2022 · 5 citations
  4. 4Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases2017 · 47 citations
  5. 5Health Care Use and Decision Making Among Lower-Income Families in High-Deductible Health Plans2010 · 84 citations